EZZ Life Science Holdings Ltd (ASX: EZZ) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
EZZ Life Science Holdings Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$79.50 million
P/E Ratio
10.52
Dividend Yield
2.61%
Shares Outstanding
47.04 million
Earnings per share
0.146
Dividend per share
0.04
Year To Date Return
8.51%
Earnings Yield
9.51%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
EZZ Life Science Holdings Ltd (ASX: EZZ)
Latest News
Healthcare Shares
Up 630% this year AND profitable! This small ASX healthcare share is glowing
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 24 Nov 2025 | $0.0200 | 100.00% | Final | 23 Dec 2025 |
| 16 May 2025 | $0.0200 | 100.00% | Interim | 17 Jun 2025 |
| 05 Nov 2024 | $0.0200 | 100.00% | Final | 09 Dec 2024 |
| 16 May 2024 | $0.0150 | 100.00% | Interim | 17 Jun 2024 |
| 30 Oct 2023 | $0.0100 | 100.00% | Final | 08 Dec 2023 |
| 22 May 2023 | $0.0098 | 100.00% | Interim | 23 Jun 2023 |
| 03 Nov 2022 | $0.0045 | 100.00% | Final | 16 Dec 2022 |
| 09 Nov 2021 | $0.0045 | 100.00% | Final | 16 Dec 2021 |
EZZ ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About EZZ Life Science Holdings Ltd
EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity,human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.
EZZ Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 10 Feb 2026 | $1.69 | $0.06 | 3.69% | 11,515 | $1.63 | $1.71 | $1.63 |
| 09 Feb 2026 | $1.63 | $0.09 | 5.88% | 23,657 | $1.55 | $1.71 | $1.55 |
| 06 Feb 2026 | $1.53 | $-0.02 | -1.29% | 32,191 | $1.51 | $1.55 | $1.48 |
| 05 Feb 2026 | $1.55 | $-0.01 | -0.64% | 20,027 | $1.57 | $1.57 | $1.51 |
| 04 Feb 2026 | $1.57 | $-0.05 | -3.11% | 23,906 | $1.59 | $1.67 | $1.55 |
| 03 Feb 2026 | $1.61 | $-0.03 | -1.83% | 9,501 | $1.70 | $1.70 | $1.61 |
| 02 Feb 2026 | $1.64 | $-0.13 | -7.34% | 65,564 | $1.75 | $1.75 | $1.55 |
| 30 Jan 2026 | $1.77 | $-0.06 | -3.27% | 16,907 | $1.84 | $1.85 | $1.77 |
| 29 Jan 2026 | $1.84 | $0.00 | 0.00% | 7,456 | $1.84 | $1.84 | $1.79 |
| 28 Jan 2026 | $1.84 | $0.00 | 0.00% | 2,337 | $1.86 | $1.86 | $1.84 |
| 27 Jan 2026 | $1.83 | $-0.02 | -1.08% | 42,196 | $1.88 | $1.88 | $1.83 |
| 23 Jan 2026 | $1.85 | $-0.13 | -6.57% | 10,029 | $1.98 | $1.98 | $1.85 |
| 22 Jan 2026 | $1.98 | $0.09 | 4.76% | 33,305 | $1.90 | $2.02 | $1.90 |
| 21 Jan 2026 | $1.89 | $-0.09 | -4.56% | 12,498 | $1.97 | $1.97 | $1.85 |
| 20 Jan 2026 | $1.98 | $0.01 | 0.51% | 106,999 | $2.00 | $2.06 | $1.95 |
| 19 Jan 2026 | $1.97 | $0.18 | 10.06% | 53,714 | $1.85 | $1.99 | $1.82 |
| 16 Jan 2026 | $1.79 | $0.06 | 3.47% | 15,127 | $1.73 | $1.88 | $1.73 |
| 15 Jan 2026 | $1.73 | $-0.08 | -4.42% | 48,580 | $1.81 | $1.81 | $1.73 |
| 14 Jan 2026 | $1.81 | $-0.01 | -0.55% | 44,877 | $1.83 | $1.89 | $1.72 |
| 13 Jan 2026 | $1.83 | $-0.18 | -9.00% | 77,880 | $2.00 | $2.00 | $1.83 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 11 Dec 2025 | Ivan Oshry | Buy | 5,000 | $7,375 |
Conversion of securities.
|
| 11 Dec 2025 | Ivan Oshry | Exercise | 5,000 | $7,375 |
Conversion of securities. 5,000 Performance Rights
|
| 11 Dec 2025 | Lily (Hao) Huang | Exercise | 5,000 | $7,375 |
Conversion of securities. 5,000 Performance Rights
|
| 11 Dec 2025 | Lily (Hao) Huang | Buy | 5,000 | $7,375 |
Conversion of securities.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Ivan Oshry | Non-Executive Director | Oct 2020 |
Mr Oshry has 30 years of experience of legal practice in Australia and
internationally, specialising in commercial and corporate law. He was formerly a senior partner at Fluxmans Attorneys in Johannesburg, South Africa and headed up the corporate department at Kemp Strang (which merged with Thomson Geer) in Sydney. He is Chair of Risk Committee and Member of Human Resources Committee. |
| Ms Lily (Hao) Huang | Non-Executive Director | Oct 2020 |
Ms Huang has 20 years of experience in the wealth management and banking industry. She has been working with the Raffles Focus Fund Australia since 2021 as Executive Managing Partner and was previously Vice President with Citi Group Australia. She is Chair of Human Resources Committee and Member of Audit and Risk Committee.
|
| Mr Mark (Qizhou) Qin | Chief Executive OfficerExecutive Director | Sep 2018 |
Mr Qin is a co-founder of the Company with a track record of success in the skin care and health supplements industries. He has a background in management consulting and experience in sales and marketing. Prior to co-founding the Company in 2018, he co-founded marketing consulting firm, CE International.
|
| Ms Christine Chen | Executive Director | Jan 2026 |
Ms Chen brings experience in finance, taxation and operational management. Her professional background includes senior tax advisory experience with an accounting firm, providing technical and commercial expertise.
|
| Ms Janice Hsu | Non-Executive Director | Jan 2026 |
Ms Hsu brings experience across administration, stakeholder engagement and community services, together with organisational and communication skills. She has held roles involving client support, intake and referral services, and administrative coordination.
|
| Mr Gary Liu | Non-Executive Director | Jan 2026 |
--
|
| Mr Jay Richard Stephenson | Company Secretary | Feb 2025 |
-
|
| Anthony Guarna | Chief Financial Officer |
-
|
|
| Jay Richard Stephenson | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Macquarie Holdings Pty Ltd | 17,016,000 | 36.07% |
| Jnj Mok Pty Ltd | 11,344,000 | 24.05% |
| Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 4,290,938 | 9.10% |
| Pinehills Limited | 1,297,350 | 2.75% |
| Qizhouqin | 1,000,000 | 2.12% |
| Mars Family Investment Pty Ltd <Mars Family A/C> | 583,335 | 1.23% |
| Mrzhaoyingwang | 472,969 | 1.00% |
| Mrhaitao Zheng | 458,000 | 0.97% |
| Mr Yong Cao | 450,000 | 0.95% |
| Aurion Truenorth Group Limited | 308,000 | 0.65% |
| Miss Jing Chen | 302,231 | 0.64% |
| Ryde Asset Management Pty Ltd <Sunshine Elisa A/C> | 250,000 | 0.53% |
| Mrorendanziger | 240,302 | 0.51% |
| Citicorp Nominees Pty Limited | 208,344 | 0.44% |
| Jing Chen & Shuping Zhang <Stevenson Family A/C> | 200,000 | 0.42% |
| Mrzhaoyingwang i | 150,000 | 0.32% |
| Msxiaojing Wang | 150,000 | 0.32% |
| Miss Jiasui Li | 142,000 | 0.30% |
| Mr George Khouri | 139,500 | 0.30% |
| Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> | 132,156 | 0.29% |
